Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/15/2003EP1352084A2 Method for identifying modulators of bace
10/15/2003EP1352070A2 A fibrin/fibrinogen-binding conjugate
10/15/2003EP1352069A2 Nucleic acids that code for oxidosqualene cyclases
10/15/2003EP1352066A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/15/2003EP1352065A2 Polypetides and nucleic acids encoding same
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352055A1 Map kinase integrin-binding domain
10/15/2003EP1352052A1 Ancillary composition for the preparation of committed mature dentritic cells
10/15/2003EP1352030A1 Impact modified polyamide composition
10/15/2003EP1351992A2 Hybrid peptides for treatment of bacteremia and septicemia
10/15/2003EP1351986A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351984A2 Amidated glucagon-like peptide-1
10/15/2003EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351977A1 Antimicrobial pseudopeptides
10/15/2003EP1351976A2 Gpe analogs
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351841A2 Oil maintenance indicator
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1351742A2 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
10/15/2003EP1351711A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/15/2003EP1351710A2 Compositions containing inclusion complexes
10/15/2003EP1351709A2 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
10/15/2003EP1351708A1 Therapeutic agent comprising a b-subunit of a protein toxin
10/15/2003EP1351707A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/15/2003EP1351706A2 Method for treating hemophilia b
10/15/2003EP1351705A1 Compositions for treatement of hemorrhaging with activated factor viia in combination with fibrinogen
10/15/2003EP1351704A2 Storage stable powder compositions of interleukin-4 receptor
10/15/2003EP1351703A2 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation
10/15/2003EP1351702A1 Trem-1 splice variant for use in modifying immune responses
10/15/2003EP1351701A2 Active metabolite of antifungal compound
10/15/2003EP1351699A1 Methods for improved diagnosis and treatment of mycobacterial infections
10/15/2003EP1351697A2 Pharmaceutical for stimulating the regeneration of tissues
10/15/2003EP1351696A2 Composition for delivery of hematopoietic growth factor
10/15/2003EP1351695A1 Camptothecin compounds with a sulfhydryl group
10/15/2003EP1351679A2 Method and composition for the treatment of diabetic neuropathy
10/15/2003EP1351675A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate
10/15/2003EP1351663A1 Cosmetic and/or pharmaceutical preparations
10/15/2003EP1351662A1 Cosmetic and/or pharmaceutical preparations
10/15/2003EP1351648A2 Carrier vectors through an epithelium with tight junctions
10/15/2003EP1244427B1 Pharmaceutical compositions for oral administration
10/15/2003EP1189627B1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
10/15/2003EP0975370B1 Composition and method for enhancing transport across biological membranes
10/15/2003EP0915736B1 Filter sheet and process for purifying photoresist composition employing the filter sheet
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds
10/15/2003EP0796276B1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
10/15/2003EP0784480B1 Use of erythropoietin in the treatment of rheumatoid arthritis
10/15/2003EP0750494B1 Hydrophobic drug delivery systems
10/15/2003EP0716591B1 USE OF ApoE FOR BINDING TAU AND MAP2c PROTEINS AND FOR TREATING ALZHEIMER'S DISEASE
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003EP0585398B1 Hcv genomic sequences for diagnostics and therapeutics
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449443A 真菌细胞壁合成基因 Fungal cell wall synthesis genes
10/15/2003CN1449440A Masp-2, a complement-fixing enzyme, and uses for it
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449409A Promyostatin peptides and methods of using same
10/15/2003CN1449408A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
10/15/2003CN1449407A Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acidor a glutamine in the form of physiologically acceptable
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449292A Solution preparations stabilized over long time
10/15/2003CN1449291A Novel specific mechanism for inhibiting adherence of platelets to collagen
10/15/2003CN1449290A Combinations of dalfopristine/quinupristine with cefpirome
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/15/2003CN1448406A Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/15/2003CN1448405A Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof
10/15/2003CN1448404A Human truncated recombination soluble TRAIL-180 protein and application for preparing tumour-curing medicine thereof
10/15/2003CN1448403A Human protein with cancer cell growth suppressing function and its coding sequence
10/15/2003CN1448182A Product containing eosinophilic,basophilic and high-temp. resistant microbe gene product and use thereof
10/15/2003CN1448181A New use of recombination human nerve growth factor used for preparing medicine of treating drug-induced peripheral nerve desease in carcinosis chemotherapy
10/15/2003CN1448180A Prep. of capsule for promoting hepatocyte growth hormone
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124343C Brain derived naurotrophic factor
10/15/2003CN1124342C Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor
10/15/2003CN1124283C Peptide, bronchodilator and blood flow ameliorant
10/15/2003CN1124282C Conformationally constrained backbone cyclized somatostatin analogs
10/15/2003CN1124281C Somatostatin polypeptide analog and its application
10/15/2003CN1124158C Drug composition comprising albumin as active ingredient
10/15/2003CN1124157C Pharmaceutical compositions
10/15/2003CA2381830A1 Compositions comprising thylakoids useful in the modulation of the inflammation process
10/14/2003US6632936 Anticancer agents
10/14/2003US6632928 Immunotoxins and methods of inducing immune tolerance
10/14/2003US6632927 Complementary determining region grafted antibody heavy chain with a variable region domain of acceptor framework and donor antigen binding regions
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632921 Administering as topical fungicide against Candida
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632811 Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell
10/14/2003US6632795 Treatment of cancer
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632793 Immunological activity for a peptide of the limulus anti-LPS factor
1 ... 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 ... 3163